- ISIN FR0004032746
- Land Frankreich
Aktuelle Research
News Funktionen
Weitere Funktionen
21 June 2018
Neovacs S.A.
Original-Research: Neovacs S.A. (von GBC AG):
19 December 2017
Neovacs S.A.
Original-Research: Neovacs S.A. (von GBC AG): Kaufen
9 August 2017
Neovacs S.A.
Original-Research: Neovacs S.A. (von GBC AG): Kaufen
10 July 2017
Neovacs S.A.
Original-Research: Neovacs S.A. (von GBC AG): Kaufen
23 March 2017
Neovacs S.A.
Original-Research: Neovacs S.A. (von GBC AG): BUY
17 March 2017
Neovacs S.A.
Original-Research: Neovacs S.A. (von GBC AG): Kaufen
31 October 2016
Neovacs S.A.
Original-Research: Neovacs S.A. (von GBC AG): BUY
24 October 2016
Neovacs S.A.
Original-Research: Neovacs S.A. (von GBC AG): Kaufen
19 July 2016
Neovacs S.A.
Original-Research: Neovacs S.A. (von GBC AG): BUY
21 June 2016
Neovacs S.A.
Original-Research: Neovacs S.A. (von GBC AG): Kaufen
Aktuelle News
News Funktionen
Weitere Funktionen
7 Dezember 2016
Neovacs S.A.
Neovacs obtains FDA ‘Fast Track’ designation for IFNα Kinoid in Lupus (SLE)
23 November 2016
Neovacs S.A.
Neovacs signs production partnership with 3P Biopharmaceuticals, a leading GMP producer of biological drugs
15 November 2016
Neovacs S.A.
NEOVACS ACQUIRES INTERFERON ALPHA MANUFACTURING TECHNOLOGY FROM AMEGABIOTECH
7 November 2016
Neovacs S.A.
Neovacs enrolls the first U.S. Patient in Phase IIb study of IFNa Kinoid for treatment of Systemic Lupus Erythematosus (SLE)
3 November 2016
Neovacs S.A.
Neovacs to attend Jefferies 2016 London Healthcare Conference November 16 & 17, 2016
12 Oktober 2016
Neovacs S.A.
Neovacs S.A. signs a cooperation agreement with the Department Immunology of Diabetes at the reputed Hospital Cochin in Paris